Correction to “Paradigm Guiding to Tapering or Discontinuation of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Patients With Rheumatoid Arthritis: Results From a Local Retrospective Cohort Study”

Author unknown

Open source

DOI
10.1111/1756-185x.70875
Published
2026-09
Container
International Journal of Rheumatic Diseases
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1756-185x.70875,
  title = {Correction to “Paradigm Guiding to Tapering or Discontinuation of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Patients With Rheumatoid Arthritis: Results From a Local Retrospective Cohort Study”},
  year = {2026},
  journal = {International Journal of Rheumatic Diseases},
  doi = {10.1111/1756-185x.70875},
  url = {https://doi.org/10.1111/1756-185x.70875}
}

RIS

TY  - JOUR
TI  - Correction to “Paradigm Guiding to Tapering or Discontinuation of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Patients With Rheumatoid Arthritis: Results From a Local Retrospective Cohort Study”
PY  - 2026
JO  - International Journal of Rheumatic Diseases
DO  - 10.1111/1756-185x.70875
UR  - https://doi.org/10.1111/1756-185x.70875
ER  - 

APA

Correction to “Paradigm Guiding to Tapering or Discontinuation of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Patients With Rheumatoid Arthritis: Results From a Local Retrospective Cohort Study”. (2026). International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70875

Source records